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Background: The genetic basis involved in multiple sclerosis (MS) susceptibility was not completely revealed by
genome-wide association studies. Part of it could lie in repetitive sequences, as those corresponding to human
Endogenous Retroviruses (HERVs). Retrovirus-like particles were isolated from MS patients and the genome of
theMS-associated retrovirus (MSRV)was the founder of the HERV-W family.We aimed to ascertain which chro-
mosomal origin encodes the pathogenic ENV protein by genomic analysis of the HERV-W insertions.
Methods/results: In silico analyses allowed to uncover putative open reading frames containing the speciﬁc
sequence previously reported for MSRV-like envelope (env) detection. Out of the 261 genomic insertions of
HERV-W env, only 9 copies harbor the speciﬁc primers and probe featuring MSRV-like env. The copy from chro-
mosome 20 was further studied considering its size, a truncated homologue of the functional HERV-W env se-
quence encoding syncytin. High Resolution Melting analysis of this sequence identiﬁed two single nucleotide
polymorphisms, subsequently genotyped by Taqman chemistry in 668 MS patients and 678 healthy controls.
No signiﬁcant association of these polymorphisms with MS risk was evidenced. Transcriptional activity of this
MSRV-like env copywas detected in peripheral bloodmononuclear cells from patients and controls. RNA expres-
sion levels of chromosome 20-speciﬁc MSRV-like env did not show signiﬁcant differences between MS patients
and controls, neither were related to genotypes of the two mentioned polymorphisms.
Conclusions: The lack of association withMS risk of the identiﬁed polymorphisms together with the transcription
results discard chromosome 20 as genomic origin of MSRV-like env.© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Multiple sclerosis (MS) is a chronic inﬂammatory and neurodegen-
erative disease of the central nervous system affecting young adults
[1]. Its precise etiology is not currently ascertained, but the prevailing
hypothesis accepts the trigger of poorly-deﬁned environmental factors
acting in genetically susceptible individuals. The genetic background
of these patients has been thoroughly studied and genome-wide associ-
ation studies (GWAS) have increased signiﬁcantly the number of loci
identiﬁed in MS predisposition [2,3]. Nonetheless, the overall genetic
load revealed by this robust approach does not seem to fully explain
previous estimations based on epidemiologic studies [4]. Neithert, Hospital Clínico San Carlos,
91 330 3000x7171; fax: +34
celay).
. This is an open access article underthe analysis of rare coding-region variants in known risk genes for auto-
immune diseases clariﬁedwhere themissing heritability lies [5]. In par-
allel, research on environmental factors has often pointed to different
virus putatively related with this condition [6].
Retrovirus-like particles were observed in cell cultures of MS patients
[7] and the genome of theMS-associated retrovirus, MSRV, was the foun-
der member of a human Endogenous Retrovirus family, HERV-W [8].
Some time ago the repetitive sequences within the human genome
were considered “junk DNA”, but this issue has been widely debated [9,
10] and recently, the ENCODE project has also questioned this gene-
centric view of the genome [11]. Only about 1–3% of the genome corre-
sponds to protein-coding sequences, while over 40% of the human DNA
sequence holds repeated elements, and the endogenous retroviruses
qualify for 8% of the total [12]. Most HERVs are defective for replication
by the acquisition of stop codons, frameshift mutations and deletions
[13]. Even so,MSRV virions have been reported in plasma and cerebrospi-
nal ﬂuid fromMS patients and were associated with MS pathogenesis [8,
14–16]. Moreover, potent immunopathogenic properties mediated by T
cells have been described in vivo for MSRV retroviral particles from MSthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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responsible for the observed damage [18,19]. Additionally, a recent
study demonstrated that the protein MSRV ENV can be used instead of
a mycobacterial lysate to induce Experimental Autoimmune Encephalo-
myelitis (EAE) [20].
The HERV-W retrovirus family is inserted into hundreds of genomic
positions [21]; approximately half of themhave been reduced to solitary
LTRs through evolution andmost of the remaining copies have rendered
defective. The complete MSRV genome is around 7700-nucleotide long,
with RU5, gag, pol, env, and U3R regions [22]. One functional HERV-W
env copy from chromosome 7 codes the physiological syncytin [23].
Mameli and collaborators discovered a 12-nucleotide insertion in the
transmembrane moiety of the MSRV env gene, which was absent from
the syncytin genetic copy and might enable its discrimination [24].
Based on this insertion, the authors conﬁrmed the link between MS
and MSRV and concluded that syncytin expression does not differ in
PBMCs from MS patients and controls [24]. Since the integration site
of the true MSRV is still unknown, the unique sequence that can be
deﬁned as MSRV env is the one detected in extracellular virus particles.
Therefore, all the HERV-W env DNA sequences with the features of the
virionic MSRV env (i.e. the 12 bp insertion) must be deﬁned as “MSRV-
like” envs.
A yet unresolved issue is the genomic origin of the MSRV ENV pro-
tein. The insertion in chromosome X which contains a shortened ver-
sion of the env gene has been regarded as a good candidate, given that
this env sequence would encode a truncated syncytin-like protein of
475 amino acids [25]. In fact, a polymorphismdescribed in that chromo-
some X copywas found associatedwithMS predisposition andwith dif-
ferential expression of MSRV [26]. In the present work, we aimed to
further explore the chromosomal origin of the HERV-W ENV involved
in MS pathogenesis, as the origin found in chromosome X is not neces-
sarily the only one. GWAS do not analyze repetitive sequences from the
genome in their search for susceptibility factors, therefore we hypothe-
sized that part of the yet-undiscovered heritability could reside in these
repetitive sequences.2. Methods
2.1. Patients and controls
The Spanish case–control study included a total of 668 MS patients
(64% females) and 678 healthy controls (57% females), with mean ages
of 40 ± 9y and 41 ± 17y, respectively. All Caucasian participants were
recruited froma single center, Hospital Clínico San Carlos,Madrid.MS di-
agnosis was established according to McDonald's criteria [27]. MS pa-
tients [age at onset (mean ± SD): 26 ± 9y] were classiﬁed in relapsing
remitting (81%), primary progressive (9%) and secondary progressive
(10%). None of the control subjects reported ﬁrst or second degree rela-
tives with any immune-mediated disease. All subjects were recruitedFig. 1. Scheme comparing theHERV-W envORFs from chromosome7 (syncytin), chromosomeX
Black boxes at 1452 nt and at 1515 nt indicate the 12 bp insertion to identify MSRV-like env
sequences compared with syncytin.after written informed consent and the Ethics Committee from Hospital
Clínico San Carlos approved this study. All research was conducted
according to the principles expressed in the Declaration of Helsinki.
2.2. In silico analysis
The MSRV-env sequence (AF331500) was aligned with the human
genome assembly GRCh37.p5 using BLAST (http://www.ensembl.org).
The query results were analyzed by pDRAW32 (developed by AcaClone,
http://www.acaclone.com) to identify putative open reading frames
(ORFs) containing the speciﬁc primers and probe reported for MSRV
env RNA detection [24]. Then, sequences were compared using a multi-
ple sequence alignment tool (www.ebi.ac.uk/Tools/msa/clustalw2/) in
order to ﬁnd differential sequences for each insertion.
2.3. Expression analysis
RNA was extracted from peripheral blood mononuclear cells
(PBMCs) from fresh blood by centrifugation in CPT tubes (Becton
Dickinson), using the Qiamp RNA Blood Mini kit (Qiagen). After
DNAse treatment, RNA sample volumes adjusted to 10 ng/μl were
retrotranscribed using First Strand cDNA Synthesis kit (Roche Diag-
nostics, S.L. Barcelona, Spain) with OligodT primers. Relative expres-
sion of MSRV env was measured by the 2e−ΔΔCt method. In short,
quantitative real time PCR of the cDNA used a probe (CGCTCTAACT
GCTTCCTGCT) and primers (forward: TATTGGGGAGGTGGCTGAT;
reverse: GCTACAAATCATTCTTCAAATGGA) designed using PRIMER3
v4.0 software (http://frodo.wi.mit.edu/) for MSRV-like env derived
from chromosome 20, and Glucuronidase-beta as housekeeping
gene (HKG, GUS-B assay from Applied Biosystems). Each ampliﬁca-
tion included samples with their no-RT controls to detect possible
genomic DNA contamination. Assays for the detection of GUS-B
and chromosome 20 HERV-W env were considered acceptable
when: 1) the Ct for the HKG was lower than the Mean + 2 ∗ S.D.
of all samples; 2) no ampliﬁcation was detected in the no-RT control;
and 3) duplicates of each sample presented less than 2% of variability on
Ct basis.
2.4. High Resolution Melting (HRM) analysis of MSRV-like env locus in
chromosome 20 and genotyping
A PCR preparatory step was conducted for this chromosomal region
(for primers and PCR ampliﬁcation conditions see Supplementary
Table 1). The PCR product containing the MSRV-env region of chromo-
some 20 was diluted 1/80 on sterile water, and then used as template
to perform HRM analysis with a set of 12 pairs of primers that were
designed using PRIMER3 v4.0 software [28].Melting curveswere discrim-
inated in a 7900HT Fast Real-Time PCR System (Applied Biosystems,
Foster City, CA, USA), according to the manufacturer's recommendations.and chromosome 20. Arrows represent transcript origins and asterisks depict stop codons.
. Empty boxes: 12 bp deletion. Light and dark gray sequences indicate non homologous
Fig. 2. The HERV-W insertion in chromosome 20. The insertion includes a truncated pol gene, an env gene with 88% homology to MSRV env and RU3 regions.
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of a potential mutation or single nucleotide polymorphism (SNP), the
sample was diluted 1/20 on sterile water and sequenced using BigDye
Cycle sequencing kit (Applied Biosystems). Any variant conﬁrmed by
sequencing was then genotyped by TaqMan technology in a 7900HT
Fast Real-Time PCR system, under conditions recommended by the man-
ufacturer (Applied Biosystems, Foster City, CA, USA).Fig. 3. Two single nucleotide polymorphisms (SNPs), T/C and T/G changes (NCBI_ss# SNP1: 97422.5. Statistical analysis
Statistical analyses were performed using SPSS 15.0. Linkage disequi-
librium values (D′) and Hardy–Weinberg equilibrium were tested with
Haploview 4.0 software. Chi-Square test was used to compare allele
and genotype frequencies. Mann–Whitney U test was used to compare
MSRV-like env relative expression between two groups. Statistically93065 and SNP2: 974293066), identiﬁed within the HERV-W insertion in chromosome 20.
Table 1
Allelic and genotypic frequencies of both SNPs identiﬁed in the HERV-W copy of chromo-
some 20 in MS patients and controls.
SNP1 MS Controls
n % n %
TT 495 75 496 73
TC 153 23 168 25
CC 14 2 14 2
T 1143 86 1160 86
C 181 14 196 14
SNP2 MS Controls
n % n %
TT 652 99 652 98
TG 9 1 15 2
GG 0 0 0 0
GG 0 0 0 0
G 9 1 15 1
165J. Varadé et al. / BBA Clinical 3 (2015) 162–167signiﬁcant differences were considered when the p-value was lower
than 0.05.
3. Results
In order to explore the genomic insertions of HERV-W env that
matchwith the publishedMSRV env sequence (AF331500), homologies
were searched in the human genome assembly GRCh37.p5 using BLAST
(see Methods). The overall 261 sequences resulting from this query
were analyzed by pDRAW32 to identify putative ORFs harboring the
speciﬁc probe and primers reported for MSRV-like env RNA detection
[24]. Only 9 out of the 261 sequencesmet these criteria andwere selected
for further analyses (Supplementary Fig. 1). From these genomic inser-
tions of MSRV-like env, the two of them with ORFs around 10% shorter
than the physiological syncytin (1617 bp) were: one located in chromo-
some X (1425 bp) and the other in chromosome 20 with 1416 bp
(Fig. 1). The region of chromosome X which would encode a truncated
syncytin protein has been previously studied [26] and in the present
work we focused on the other plausible candidate in chromosome 20
(for protein alignments see Supplementary Fig. 2).
A preparative PCR ampliﬁcation step fromgenomicDNAwas conduct-
ed to isolate the speciﬁc MSRV-like env copy in chromosome 20 (Fig. 2),
yielding a 4232 bp product used as template to perform HRM analysis
in overlapping amplicons (for primers used and PCR conditions seeFig. 4. Relative expression of HERV-W env copy on chromosome 20 in 52 MS patients and 53 h
inside the boxes represent medians, whiskers represent standard deviations.Supplementary Table 1). Whenever a potential variant was detected in
an initial screening of 100 samples, it was validated by sequencing and
then analyzed by TaqMan technology in the overall 668 MS patients
and 678 healthy controls. Two SNPs were identiﬁed following this proce-
dure: T/C and T/G changes at positions 221 and 285 from the beginning of
the ampliﬁcation product (D′ = 35%, NCBI_ss# SNP1: 974293065 and
SNP2: 974293066) (Fig. 3).
Genotyping success was over 95% for both patient and control
cohorts and no departure from Hardy–Weinberg equilibrium was
observed. However, no signiﬁcant differences were found in the allelic
or genotypic frequencies between MS patients and ethnically matched
controls (χ2 test: p N 0.05, Table 1).Moreover, no signiﬁcant associations
(Mann–Whitney U test: p N 0.05) were found between alleles or geno-
types of these SNPs and the RNA expression ofMSRV env speciﬁcally de-
rived from the chromosome 20 copy (Fig. 4).
4. Discussion
In the present work, we aimed to shed some light on the genomic
origin of the reported MSRV ENV protein previously identiﬁed as MS
pathogenic co-factor. Speciﬁcally, we pursued to elucidate the putative
role in MS risk of the insertion of MSRV-like env in chromosome 20 as
one of the plausible candidates by size, together with the insertion in
chromosome X already studied by our group [26]. Both chromosomal
origins showed similar lengths of their respective ORFs, 10% shorter
than the one measured for syncytin [29] and could putatively originate
functional proteins. The ENV protein has been recently evidenced with-
in post-mortemMS brain lesions [15,30–32]. MSRV ENV induces human
monocytes to produce proinﬂammatory cytokines through engagement
of CD14 and TLR4 [19]. Kremer and collaborators demonstrated that the
ENV protein is present in close proximity to TLR4-expressing oligoden-
droglial precursor cells adjacent to MS lesions [33]. In addition, MSRV
ENV triggers a maturation process in human dendritic cells driving a
Th1-like differentiation [19].
We recently reported that the MSRV-like env copy number is
increased in PBMCs of MS patients, as an elevated MSRV-like env load
was observed in MS patients compared to controls (p = 4.15 e-7)
[34]. Moreover, in our cohort the transcription levels of MSRV-like env
were higher in MS patients than in controls (Mann–Whitney
U test: p = 0.004) [26], consistent with previous ﬁndings [24,35].
Nonetheless, knowledge is still lacking about which chromosomal
location(s) harboring speciﬁc retroviral copy(ies) originate(s) these
induced levels of transcription. Once the RNA expression in PBMCs wasealthy blood donors (A) and stratiﬁed by genotype of the identiﬁed SNPs (B and C). Lines
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ﬁed envelope proteins: those derived from chromosomes X26 and 20.
It has been demonstrated that MSRV-like env expression in brain macro-
phages within MS lesions is consistent with the observed expression in
MS PBMCs, supporting the rationale for its ex-vivo detection in peripheral
blood [30]. Nonetheless, our ﬁndings regarding the transcriptionally ac-
tive long ORF derived from chromosome 20 dismiss this copy as a pre-
dominant origin of the MSRV pathogenic effect.
Previous results of GWAS in MS demonstrated associations with
three loci within chromosome 20 including the following genes: CD40,
TNFRSF6B andCYP24A1 [2], the latter at 1Mb of theHERV-W insert stud-
ied in the presentwork. Considering that repetitive sequences of the ge-
nome have not been explored in the GWAS, this seemed an adequate
analysis to advance in the unresolved issue of the missing heritability
of this complex disease [4].Moreover, one of the proposed co-factors re-
peatedly involved in the pathogenesis of MS is the Epstein–Barr virus,
which was reported to activate in vitro the HERV-W family of human
endogenous retroviruses [36]. The speciﬁc PCR ampliﬁcation of the ge-
nomic region of chromosome 20 including theMSRV-like env sequence
and subsequent HRM analysis led to the identiﬁcation of two polymor-
phisms within this repetitive insertion. However, the performed case–
control study did not detect signiﬁcant differences in allelic or genotypic
frequencies for these SNPs. Therefore, the results obtained in this study
do not encourage further investigation of this MSRV-like env insertion
as responsible of part of the genetic risk in MS patients. Despite the
mentioned similar size of the two MSRV-like env copies from chromo-
somes 20 and X, apparent differences have been found between them.
One polymorphism identiﬁed in chr. X, rs6622139*T, was associated
with higher MSRV-like env expression (Mann–Whitney U test: p =
0.003), while the two polymorphisms found in chromosome 20 did
not show evidence of associationwith chromosome20-speciﬁc RNAex-
pression levels. Additionally, rs6622139 was associated in women with
MS susceptibility and severity [26]. These results point to the insertion
in chromosome X and not the one in chromosome 20 as involved in
the origin of MSRV ENV.
Suggestive of its potential pathogenic activity, signiﬁcant decreases in
seroreactivities toHERV-Wenvelope antigens, closely linked to efﬁcacy of
interferon-beta therapy were previously demonstrated [37] and recently,
it has been reported that after one year therapy, natalizumab inhibits the
plasma-membrane levels of the ENVprotein inMSpatients [38]. The chal-
lenge is now to turn the increasing knowledge in HERV-W to the clinical
setting, as it has proven helpful in predicting therapy outcomes [34].
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbacli.2015.02.002.Transparency document
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